A landmark moment in the world’s efforts to respond to the Ebola crisis is set to begin in the Democratic Republic of the Congo as clinical trials of an experimental therapy begin; after the National Rifle Association (NRA) posted a mocking tweet to physicians about gun violence, doctors responded in kind on Twitter; House Minority Leader Nancy Pelosi, D-California, said she is "staying on as Speaker" to protect the Affordable Care Act (ACA).
A landmark moment in the world’s efforts to respond to the Ebola crisis, as well as future crises, is set to begin in the Democratic Republic of the Congo, STAT reported. Health officials are preparing to launch a clinical trial designed to test whether experimental Ebola therapies improve patients’ chances of survival, but the trial will be complicated given the violent environment. The randomized controlled trial will compare 3 different antibody treatments and an antiviral drug to each other, rather than involving a placebo.
After the National Rifle Association (NRA) posted a mocking tweet to physicians about gun violence—just hours before a man opened fire in a California bar killing 12 people—doctors responded in kind on Twitter. The NRA suggested that “anti-gun doctors should stay in their lane” when it comes to gun control. Using the hashtag #ThisIsOurLane, physicians wrote about pulling bullets out of bodies and telling loved ones their family members were dead, often posting graphic photos, NPR reported. The NRA has long advocated to prevent the CDC from conducting research on gun violence.
House Minority Leader Nancy Pelosi, D-California, said on CBS's "Face the Nation that she is "staying on as Speaker" to protect the Affordable Care Act. Pelosi formally announced her bid for the top House leadership role after the Democrats won control of the House in last week's midterms. She also called on Republicans in Congress to join Democrats in working to protect pre-existing conditions.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen